[REGN] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -11.63%
YoY- 13.86%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 1,212,629 998,617 665,700 457,642 304,399 107,810 115,886 47.84%
PBT 292,256 327,996 203,119 147,692 76,743 -63,368 -23,132 -
Tax 96,038 133,353 110,384 60,316 -501 -863 -1,184 -
NP 196,218 194,643 92,735 87,376 76,743 -62,505 -25,474 -
Tax Rate -32.86% -40.66% -54.34% -40.84% 0.65% - - -
Total Cost 1,016,411 803,974 572,965 370,266 227,656 170,315 141,360 38.88%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 16.18 19.49 13.93 19.09 25.21 -57.98 -21.98 -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS 1.88 1.89 0.96 0.89 0.81 -0.69 -0.31 -
EPS Diluted 1.69 1.69 0.85 0.79 0.70 -0.69 -0.31 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.